ArticleJournal of multivariate analysis2019
Forward regression for Cox models with high-dimensional covariates.
Article in Journal of multivariate analysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Efficient Post-Shrinkage Estimation Strategies in High-Dimensional Cox's Proportional Hazards Models.Entropy (Basel, Switzerland) · 2025Article
- What can claims data tell us about risk factors and survival of patients with hepatocellular carcinoma? Insights from a German population-based study.Frontiers in oncology · 2025Article
- Quantile forward regression for high-dimensional survival data.Lifetime data analysis · 2023Article
- Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer.World journal of urology · 2022Article
- The clinical impact of three validated PD-L1 immunohistochemistry assays as a prognostic factor in small cell lung cancer.Translational lung cancer research · 2021Article
- Consistent Estimation of Generalized Linear Models with High Dimensional Predictors via Stepwise Regression.Entropy (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Forward regression, a classical variable screening method, has been widely used for model building when the number of covariates is relatively low. However, forward regression is seldom used in high-dimensional settings because of the cumbersome computation and unknown theoretical properties. Some recent works have shown that forward regression, coupled with an extended Bayesian information criterion (EBIC)-based stopping rule, can consistently identify all relevant predictors in high-dimensional linear regression settings. However, the results are based on the sum of residual squares from linear models and it is unclear whether forward regression can be applied to more general regression settings, such as Cox proportional hazards models. We introduce a forward variable selection procedure for Cox models. It selects important variables sequentially according to the increment of partial likelihood, with an EBIC stopping rule. To our knowledge, this is the first study that investigates the partial likelihood-based forward regression in high-dimensional survival settings and establishes selection consistency results. We show that, if the dimension of the true model is finite, forward regression can discover all relevant predictors within a finite number of steps and their order of entry is determined by the size of the increment in partial likelihood. As partial likelihood is not a regular density-based likelihood, we develop some new theoretical results on partial likelihood and use these results to establish the desired sure screening properties. The practical utility of the proposed method is examined via extensive simulations and analysis of a subset of the Boston Lung Cancer Survival Cohort study, a hospital-based study for identifying biomarkers related to lung cancer patients' survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.